Cargando…
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
BACKGROUND: Loco-regional treatment strategies of colorectal cancer (CRC) metastases are evolving, but biological markers that can benefit patients and assist physicians in clinical decisions are lacking. The primary objective of this systematic review and meta-analysis is to investigate the current...
Autores principales: | Callesen, Louise B., Takacova, Tana, Hamfjord, Julian, Würschmidt, Florian, Oldhafer, Karl J., Brüning, Roland, Arnold, Dirk, Spindler, Karen-Lise G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634210/ https://www.ncbi.nlm.nih.gov/pubmed/36339929 http://dx.doi.org/10.1177/17588359221133171 |
Ejemplares similares
-
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors –
can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
por: Solar Vasconcelos, Joao Paulo, et al.
Publicado: (2022) -
Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
por: Piercey, Oliver, et al.
Publicado: (2023) -
Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023) -
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
por: Boutin, Mélina, et al.
Publicado: (2023)